申请人:The Board of Trustees of the Leland Stanford Junior University
公开号:US20160113919A1
公开(公告)日:2016-04-28
This disclosure provides a method of treating a subject infected with a mycobacteria of the
M. tuberculosis
complex or infected with an atypical
mycobacterium
. Aspects of the method include administering to a subject in need thereof a therapeutically effective amount of an enantiomerically pure (R)-chloroquine agent. The (R)-chloroquine agent may be an analog or derivate of chloroquine having a particular stereochemistry at the position located alpha to the amino-quinoline core of the chloroquine agent. Also provided are methods of inhibiting mycobacteria of the
M. tuberculosis
complex or other atypical mycobacteria in a cell. Kits and pharmaceutical compositions for practicing the subject methods are also provided.